Shareholders' Equity (Tables)

12 Months Ended

Dec. 31, 2021

Equity [Abstract]

Share repurchase programs

The following share repurchase programs have been authorized by the Board:

In billions Authorization Date	Authorized		Remaining as of December 31, 2021
December 9, 2021 (“2021 Repurchase Program”)	$	10.0	$	10.0
November 2, 2016 (“2016 Repurchase Program”)	15.0		—

Schedule of regulatory Requirements

The combined statutory net income for the years ended and estimated combined statutory and capital surplus at December 31, 2021, 2020 and 2019 for the Company’s insurance and HMO subsidiaries were as follows:

In millions	2021		2020		2019
Statutory net income	$	3,302	$	3,667	$	2,842
Estimated statutory capital and surplus	14,879		13,238		10,975

Statutory accounting practices disclosure

At December 31, 2021, these amounts were as follows:

In millions
Estimated minimum statutory surplus required by regulators	$	7,261
Investments on deposit with regulatory bodies	794
Estimated maximum dividend distributions permitted in 2022 without prior regulatory approval	2,939